MACK

Merrimack Pharmaceuticals Inc (NASDAQ: MACK) is having an incredibly rough start to the trading session in the pre-market hours this morning, and for good reason. The company was forced to terminate a drug trial due to futility. So, it comes as no surprise that upset investors are sending the stock tumbling. Today, we’ll talk about: … Read more

Merrimack Pharmaceuticals Inc (NASDAQ: MACK) is having an overwhelmingly rough start to the trading session this morning, and for good reason. The company announced that it is scrapping the development of a treatment due to poor clinical trial results. Of course, the news upset investors who are sending the stock spiraling down. Today, we’ll talk … Read more

Merrimack Pharmaceuticals Inc (NASDAQ: MACK) Merrimack Pharmaceuticals was having a relatively interesting start to the trading session today. When the session started, the stock was slightly in the red. From there, it made a quick push to the green before falling back down. Nonetheless, that all changed minutes ago, as the stock started to spike upward. … Read more

Merrimack Pharmaceuticals Inc (NASDAQ: MACK) Merrimack Pharmaceuticals is having a rough day in the market today, and for good reason. Amid the backdrop of a struggling company, they have chosen to cut a large portion of their workforce. On top of that, it was announced today that the current CEO of the company has made … Read more

Merrimack Pharmaceuticals Inc (NASDAQ: MACK) Merrimack Pharmaceuticals is having an incredibly rough day in the market today, and for good reason. The company released its earnings report for the second quarter. Unfortunately, the report was negative. Today, we’ll talk about what we saw from the earnings report, how the stock reacted to the news, and … Read more